AKT1 and glioblastoma: Some researchers have found that cytotoxic drug withaferin A, which is involved in oxidative stress, can increase the sensitivity of glioblastoma to TMZ treatment by reducing MGMT expression and activating apoptosis induced by Akt/mTOR signaling pathway (Grogan et al. 2014).